This pilot study is the first to identify RT-induced changes in the phenotypic profiles of circulating CD8+ and CD4+ T cells in NPC patients and their association with post-RT plasma EBV DNA clearance and tumor recurrence. The gene discussed is CD8A; the disease is nasopharyngeal carcinoma.